Regueiro M, Fischer M, Bossuyt P, McGinnis K, et al. Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study. Inflamm Bowel Dis 2024 Aug 2:izae166. doi: 10.1093.
PMID: 39093640